Search research articles
Contact Us
Filters
Showing results (111-120 of 152) with videos related to
Page
of 16
Sort By:
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
May 9, 2025
Detection of HER2-Low Lesions Using HER2-Targeted PET Imaging in Patients with Metastatic Breast Cancer: A Paired HER2 PET and Tumor Biopsy Analysis
Randy Yeh, Fresia Pareja, Parnian Shobeiri, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
May 7, 2016
Detection of HER2-Positive Metastases in Patients with HER2-Negative Primary Breast Cancer Using 89Zr-Trastuzumab PET/CT
Gary A Ulaner, David M Hyman, Dara S Ross, et al.
Cancer
|
April 21, 2012
Standardized uptake value by positron emission tomography/computed tomography as a prognostic variable in metastatic breast cancer
Patrick G Morris, Gary A Ulaner, Anne Eaton, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
March 2, 2023
Summary: Appropriate Use Criteria for Estrogen Receptor-Targeted PET Imaging with 16α-<sup>18</sup>F-Fluoro-17β-Fluoroestradiol
Gary A Ulaner, David A Mankoff, Amy S Clark, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 25, 2016
<sup>18</sup>F-Fluoroestradiol PET/CT Measurement of Estrogen Receptor Suppression during a Phase I Trial of the Novel Estrogen Receptor-Targeted Therapeutic GDC-0810: Using an Imaging Biomarker to Guide Drug Dosage in Subsequent Trials
Yingbing Wang, Karen L Ayres, Debra A Goldman, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
July 18, 2024
<sup>61</sup>Cu-PSMA-Targeted PET for Prostate Cancer: From Radiotracer Development to First-in-Human Imaging
Tais Basaco Bernabeu, Rosalba Mansi, Luigi Del Pozzo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 25, 2019
Impact of FDG PET Imaging for Expanding Patient Eligibility and Measuring Treatment Response in a Genome-Driven Basket Trial of the Pan-HER Kinase Inhibitor, Neratinib
Gary A Ulaner, Cristina Saura, Sarina A Piha-Paul, et al.
Radiology
|
December 9, 2025
<sup>61</sup>Cu-NODAGA Prostate-specific Membrane Antigen Imaging and Therapy for Prostate Cancer: Phase 1 Trial of a New Class of <sup>61</sup>Cu-labeled PET Radiotracers
Gary A Ulaner, Jeffrey C Bassett, Ryan Reddy, et al.
Clinical Nuclear Medicine
|
December 5, 2022
A Tale of 3 Tracers: Contrasting Uptake Patterns of 18F-Fluciclovine, 68Ga-PSMA, and 18F-FDG in the Uterus and Adnexa
Ismaheel O Lawal, Omotayo Atinuke Adediran, Saima Muzahir, et al.
Clinical Nuclear Medicine
|
February 2, 2023
A Discordant Pattern of Uptake on 68 Ga-PSMA PET/CT Versus 18 F-Fluciclovine PET/CT in Radiation-Induced Hepatitis : Implications for Early Postradiotherapy Imaging-Based Response Assessment
Omotayo A Adediran, Ismaheel O Lawal, Saima Muzahir, et al.
Page
of 16
Search research articles
Search
Showing results (111-120 of 152) with videos related to
Sort By:
Page
of 16
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
May 9, 2025
Detection of HER2-Low Lesions Using HER2-Targeted PET Imaging in Patients with Metastatic Breast Cancer: A Paired HER2 PET and Tumor Biopsy Analysis
Randy Yeh, Fresia Pareja, Parnian Shobeiri, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
May 7, 2016
Detection of HER2-Positive Metastases in Patients with HER2-Negative Primary Breast Cancer Using 89Zr-Trastuzumab PET/CT
Gary A Ulaner, David M Hyman, Dara S Ross, et al.
Cancer
|
April 21, 2012
Standardized uptake value by positron emission tomography/computed tomography as a prognostic variable in metastatic breast cancer
Patrick G Morris, Gary A Ulaner, Anne Eaton, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
March 2, 2023
Summary: Appropriate Use Criteria for Estrogen Receptor-Targeted PET Imaging with 16α-<sup>18</sup>F-Fluoro-17β-Fluoroestradiol
Gary A Ulaner, David A Mankoff, Amy S Clark, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 25, 2016
<sup>18</sup>F-Fluoroestradiol PET/CT Measurement of Estrogen Receptor Suppression during a Phase I Trial of the Novel Estrogen Receptor-Targeted Therapeutic GDC-0810: Using an Imaging Biomarker to Guide Drug Dosage in Subsequent Trials
Yingbing Wang, Karen L Ayres, Debra A Goldman, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
July 18, 2024
<sup>61</sup>Cu-PSMA-Targeted PET for Prostate Cancer: From Radiotracer Development to First-in-Human Imaging
Tais Basaco Bernabeu, Rosalba Mansi, Luigi Del Pozzo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 25, 2019
Impact of FDG PET Imaging for Expanding Patient Eligibility and Measuring Treatment Response in a Genome-Driven Basket Trial of the Pan-HER Kinase Inhibitor, Neratinib
Gary A Ulaner, Cristina Saura, Sarina A Piha-Paul, et al.
Radiology
|
December 9, 2025
<sup>61</sup>Cu-NODAGA Prostate-specific Membrane Antigen Imaging and Therapy for Prostate Cancer: Phase 1 Trial of a New Class of <sup>61</sup>Cu-labeled PET Radiotracers
Gary A Ulaner, Jeffrey C Bassett, Ryan Reddy, et al.
Clinical Nuclear Medicine
|
December 5, 2022
A Tale of 3 Tracers: Contrasting Uptake Patterns of 18F-Fluciclovine, 68Ga-PSMA, and 18F-FDG in the Uterus and Adnexa
Ismaheel O Lawal, Omotayo Atinuke Adediran, Saima Muzahir, et al.
Clinical Nuclear Medicine
|
February 2, 2023
A Discordant Pattern of Uptake on 68 Ga-PSMA PET/CT Versus 18 F-Fluciclovine PET/CT in Radiation-Induced Hepatitis : Implications for Early Postradiotherapy Imaging-Based Response Assessment
Omotayo A Adediran, Ismaheel O Lawal, Saima Muzahir, et al.
Page
of 16